Patent · US Active

BTK inhibitors with improved dual selectivity

US11377449B2 · kind B2 · utility

3Cited by
10References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2018
Grant dateJul 5, 2022
Priority date
Expiry dateAug 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein is a tri-substituted phenyl Btk inhibitors with improved dual selectivity, a method and a composition for inhibiting Btk and treating disease associated with undesirable Btk activity (Btk-related diseases).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.